Search results
Results from the WOW.Com Content Network
The stomach is an organ of the gastrointestinal tract that sits in the abdomen. [1] Tumors of the stomach are known as gastric tumors, and can be either benign or malignant (gastric cancer). These tumors arise from the cells of the gastric mucosa which lines the stomach. Typically, most gastric tumors are cancerous and not detected until a ...
People can have benign or malignant tumors, but there are also tumors that show characteristics of cancer but aren’t yet cancerous, says Dr. Brian Slomovitz, director of gynecologic oncology at ...
However, a benign tumor is not benign in the usual sense; the name merely specifies that it is not "malignant", i.e. cancerous. While benign tumors usually do not pose a serious health risk, they can be harmful or fatal. [2] Many types of benign tumors have the potential to become cancerous through a process known as tumor progression. For this ...
Plexiform angiomyxoid myofibroblastic tumor (PAMT), also called plexiform angiomyxoma, [1] plexiform angiomyxoid tumor, [2] or myxofibroma, [3] is an extremely rare benign mesenchymal myxoid tumor along the gastrointestinal tract. Most of PAMTs occur in the gastric antral region, but they can be situated anywhere in the stomach.
Patients with abdominal pain have a higher percentage of unexplained complaints (category "no diagnosis") than patients with other symptoms (such as dyspnea or chest pain). [25] Most people who suffer from stomach pain have a benign issue, like dyspepsia . [ 26 ]
[11] [12] [13] Alternatively, they may point to non-cancerous disease processes, benign tumors, or even be within the physiological range of normal. They may appear at the primary site of cancer or be symptoms of cancer metastasis, or spread. Further workup by a trained healthcare professional is required to diagnose cancer. [12] Constitutional ...
The diameter can range from a few millimeters to more than 30 cm. Larger tumors usually cause symptoms in contrast to those found incidentally which tend to be smaller and have better prognosis. [4] [20] Large tumors tend to exhibit malignant behavior but small GISTs may also demonstrate clinically aggressive behavior. [21]
If patients present with hepatic metastases they might have remaining life span of one year with a five-year survival rate of 20–30%. In patients with localized tumor or localized lymph spread the survival rate of five years is 90%. Lastly, surgical resection of local tumor could lead to complete cure without recurrence in 20–25% of ...